Concepedia

James Oliver

JO

Statistics

Publications

2

Citations

23

H-Index

2

Active since

2007

Affiliations

Kite (United States)(Current)

James Oliver is an author at Kite (United States) specializing in oncology, t-cell therapy, and peripheral blood mononuclear cell processing.

Publications per year

2007–2016

2

Publications

2

First-in-human phase I trial of a cyclodextrin-containing polymer-camptothecin nanoparticle in patients with solid tumors

Yun Yen, Timothy W. Synold, Thomas Schluep et al. · Journal of Clinical Oncology · 2007 · 12 citations

Pharmacy, Oncology, Pharmacology +17

287. Production of KTE-C19 (Anti-CD19 CAR T Cells) for ZUMA-1: A Phase 1/2 Multi-Center Study Evaluating Safety and Efficacy in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

Marc Better, Vijay Chiruvolu, James Oliver et al. · Molecular Therapy · 2016 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17

1–2 of 2